» Download Public Reports
About 1 100 reports
- Industry report
- May 2012
- 17 pages
... To In-sourced Specialty practices decreased attractiveness of pathology to graduating medical students: - pathology & laboratory medicine as a Commodity - Anatomic pathology as an in ...
April 2012
... Medicines in oncology, virology, inflammation, metabolism and cns. Roche is also the world leader in in-vitro diagnostics, tissue-based cancer diagnostics and a pioneer in diabetes management. Roche ...
April 2012
... Licenced to lifescan, a subsidiary of johnson and johnson. This pin prick blood glucose test delivers market leading accuracy at significantly lower than existing technologies manufacturing costs. Whk ...
April 2012
... In increased growth rate estimates Adjusted market size and growth for some markets microarrays: given identified niche opportunities Elisa: decreased market size 2010/11 market size (~20%) due ...
April 2012
... The medicare framework, the national limitation amount for clinical laboratory services had been reduced in a number of instances over the past several years to a present level equal to 74% of the national ...
April 2012
... David kelso oak ridge april 20, 2012 in vitro diagnostic platforms for the developing world center for innovation in global health technologies industry academia philanthropy ...
» Purchase Premium Reports
(From $ 44 - $ 23 520)
About 1 600 reports
- $ 29 400
- Industry report
- March 2012
- by Venture Planning Group
During the next decade, the clinical chemistry and immunodiagnostics markets will undergo significant transformation. The changes will be caused convergence of new and more stringent regulations; advances ...
April 2012
$ 28 700
The growing cost-containment pressures in major industrialized nations, coupled with continued technological advances in chromagenic substrates, monoclonal antibodies, immunoassays, molecular diagnostics, ...
March 2012
$ 28 700
The growing cost-containment pressures in major industrialized nations, coupled with continued technological advances in chromagenic substrates, monoclonal antibodies, immunoassays, molecular diagnostics, ...
March 2012
$ 28 700
The infectious disease testing market is one of the most rapidly growing segments of the in vitro diagnostics industry, and the greatest challenge facing suppliers in the 21st century. Among the main ...
February 2012
$ 28 700
Complete report $28,700.  . This comprehensive seven-country report is designed to help current suppliers and potential market entrants identify and evaluate business opportunities emerging in the ...
March 2012
$ 28 500
The cancer diagnostics market is on the verge of explosion, as the researchers approach major technological breakthroughs in tumor diagnosis and therapy, discover new specific antigens, and unlock the ...
March 2012
$ 28 500
The molecular diagnostics market is unquestionably the most rapidly growing segment of the in vitro diagnostics industry. The next ten years will witness significant developments in reagent systems and ...